Larimar Therapeutics
LRMR
#7066
Rank
NZ$0.67 B
Marketcap
$10.55
Share price
0.49%
Change (1 day)
92.43%
Change (1 year)

EPS for Larimar Therapeutics (LRMR)

EPS in 2023 (TTM): -$1.53

According to Larimar Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.58. In 2022 the company made an earnings per share (EPS) of -$2.64 an increase over its 2021 EPS that were of -$5.09.

EPS history for Larimar Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.53-42.1%
2022-$2.64-48.15%
2021-$5.09-14.27%
2020-$5.93